(MedMira) (TSXV:MIR) announced that its received investigational testing authorization (ITA) from Health Canada to begin clinical trials for its Multiplo ® Complete Syphilis (TP/nTP) Antibody ...

HALIFAX, NS / ACCESSWIRE / January 9, 2025 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announced that its received investigational testing authorization (ITA) from Health Canada to begin clinical ...

HALIFAX, NS / ACCESSWIRE / January 9, 2025 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announced that its received investigational testing authorization (ITA) from Health Canada to begin clinical ...

MedMira Inc. has received investigational testing authorization from Health Canada to commence clinical trials for its Multiplo® Complete Syphilis (TP/nTP) Antibody Test. This innovative test ...

No extract is available for articles shorter than 400 words.

(MedMira) (TSXV:MIR) announced that its received investigational testing authorization (ITA) from Health Canada to begin clinical trials for its Multiplo ® Complete Syphilis (TP/nTP) Antibody ...

A blood test can determine if someone is infected. The disease is treatable. Shigemura said syphilis is also preventable with the proper use of contraceptives.

Syphilis was at its peak in the 1940s ... an infant's positive nontreponemal test reflects passively acquired antibody and the infant does not require treatment. The Centers for Disease Control ...